Pharmaceutical industry is invited to respond to amnesty for unreported trials

BMJ 1997; 315 doi: 10.1136/bmj.315.7109.683b (Published 13 September 1997)
Cite this as: BMJ 1997;315:683.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Ian Roberts, Director (Ian.Roberts@ich.ucl.ac.uk)a
  1. aChild Health Monitoring Unit, Institute of Child Health, London WC1N 1EH

    See p 622

    Editor—Alan Maynard and Karen Bloor are correct to call for regulation of the pharmaceutical industry to ensure that all data …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL